Disclosed herein are detectable moieties and detectable conjugates comprising one or more detectable moieties. In some embodiments, the disclosed detectable moieties have a narrow wavelength and are suitable for multiplexing. Also disclosed are methods of labeling one or more targets within a biological specimen using any of the detectable conjugates and/or detectable moieties described herein.

Provided are a ruthenium complex dye having a water content of 0.2% to 4.0% by mass; a dye solution including the ruthenium complex dye; a photoelectric conversion element having semiconductor fine particles having the ruthenium complex dye carried thereon; and a dye-sensitized solar cell including the photoelectric conversion element.

The invention relates to novel cationic benzoxazine-based compounds of formula (I) below, in which •R represents a hydrogen atom or a C.sub.1-C.sub.4 alkyl or C.sub.1-C.sub.4 hydroxyalkyl radical, •—R.sub.2, R.sub.3, R.sub.4 and R.sub.5 independently represent: —a hydrogen atom, —a linear C.sub.1-C.sub.4 or branched C.sub.3-C.sub.4 alkyl radical, optionally substituted with a hydroxyl radical, •L represents a linear or branched, saturated C.sub.1-C.sub.30 hydrocarbon-based chain, •CAT+ represents a cationic radical chosen from: —a cationic heterocyclic radical comprising 5 to 8 ring members containing at least one heteroatom chosen from O, N and S, —a tri(hydroxy)(C.sub.1-C.sub.4)alkylammonium radical, —a non-cationic heterocycle comprising 5 or 6 ring members containing at least one heteroatom chosen from O and N, such as pyrrolidine, substituted with a cationic radical, An− represents an anion or a mixture of anions which are organic or inorganic and are cosmetically acceptable.

##STR00001##

The invention relates to novel cationic benzoxazine-based compounds of formula (I) below, in which •R represents a hydrogen atom or a C.sub.1-C.sub.4 alkyl or C.sub.1-C.sub.4 hydroxyalkyl radical, •—R.sub.2, R.sub.3, R.sub.4 and R.sub.5 independently represent: —a hydrogen atom, —a linear C.sub.1-C.sub.4 or branched C.sub.3-C.sub.4 alkyl radical, optionally substituted with a hydroxyl radical, •L represents a linear or branched, saturated C.sub.1-C.sub.30 hydrocarbon-based chain, •CAT+ represents a cationic radical chosen from: —a cationic heterocyclic radical comprising 5 to 8 ring members containing at least one heteroatom chosen from O, N and S, —a tri(hydroxy)(C.sub.1-C.sub.4)alkylammonium radical, —a non-cationic heterocycle comprising 5 or 6 ring members containing at least one heteroatom chosen from O and N, such as pyrrolidine, substituted with a cationic radical, An− represents an anion or a mixture of anions which are organic or inorganic and are cosmetically acceptable.

##STR00001##

The present invention relates to compounds of the formula (1), (17) 18) or (20) and to the use thereof in electronic devices, and to electronic devices which contain these compounds. The invention furthermore relates to the preparation of the compounds of the formula (1), (17) 18) or (20) and to formulations contains one or more compounds of the formula (1), (17) 18) or (20).

The present invention relates to compounds of the formula (1), (17) 18) or (20) and to the use thereof in electronic devices, and to electronic devices which contain these compounds. The invention furthermore relates to the preparation of the compounds of the formula (1), (17) 18) or (20) and to formulations contains one or more compounds of the formula (1), (17) 18) or (20).

The present disclosure concerns the design, formulations, preparations and optical properties of compounds of Formulas (I) and (VI):

(charged dye.sup.m+).sub.x.Math.(counterion.sup.n−).sub.y.Math.(counterion receptor).sub.z  (I) and

(charged dye.sup.m−).sub.x.Math.(counterion.sup.n+)y.Math.(counterion receptor).sub.z  (VI).

The charged dye.sup.m+ is a cationic dye, counterion.sup.n− is an anion, and counterion receptor is a binding ligand for the counterion.sup.n−, wherein m, n, x and y are integers greater than or equal to 1, and products of x.Math.n and m.Math.y are identical for formula (I).

The charged dye.sup.m− is a anionic dye, counterion.sup.n+ is a cation, and counterion receptor is a binding ligand for the counterion.sup.n+, wherein m, n, x and y are integers greater than or equal to 1, and products of x.Math.n and m.Math.y are identical for formula (VI).

The present disclosure concerns the design, formulations, preparations and optical properties of compounds of Formulas (I) and (VI):

(charged dye.sup.m+).sub.x.Math.(counterion.sup.n−).sub.y.Math.(counterion receptor).sub.z  (I) and

(charged dye.sup.m−).sub.x.Math.(counterion.sup.n+)y.Math.(counterion receptor).sub.z  (VI).

The charged dye.sup.m+ is a cationic dye, counterion.sup.n− is an anion, and counterion receptor is a binding ligand for the counterion.sup.n−, wherein m, n, x and y are integers greater than or equal to 1, and products of x.Math.n and m.Math.y are identical for formula (I).

The charged dye.sup.m− is a anionic dye, counterion.sup.n+ is a cation, and counterion receptor is a binding ligand for the counterion.sup.n+, wherein m, n, x and y are integers greater than or equal to 1, and products of x.Math.n and m.Math.y are identical for formula (VI).

The present invention relates to compounds of formula (1) which are suitable for use in electronic devices, especially in organic electroluminescent devices.

The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds.